Reversion of the human calreticulin gene promoter to the ancestral type as a result of a novel psychosis-associated mutation

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 2, 2011, Pages 541-544

  Farokhashtiani, T ^a   Mirabzadeh, A ^a   Olad Nabi, M ^a   Ghaem Magham, Z ^a   Khorram Khorshid, H R ^a   Najmabadi, H ^a   Ohadi, M ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Calreticulin; Evolution; Mutation; Promoter; Psychosis

Indexed keywords

CALRETICULIN;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BRAIN FUNCTION; CONTROLLED STUDY; DECISION MAKING; EVOLUTION; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; LANGUAGE; MAJOR AFFECTIVE DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PROMOTER REGION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; THINKING; TRANSCRIPTION INITIATION SITE;

ANIMALS; CALRETICULIN; FEMALE; HUMANS; MALE; MUTATION; PHENOTYPE; PROMOTER REGIONS, GENETIC; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; SPECIES SPECIFICITY;

EID: 79952899183     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.12.012     Document Type: Article

References (28)

1. Aghajani A., Rahimi A., Fadai F., Ebrahimi A., Najmabadi H., Ohadi M. A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:294-295.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-Text Revised. 2000. Washington. DC: APA.
3. Arion D., Unger T., Lewis D.A., Levitt P., Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 2007, 62:711-721.
4. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008, 40:695-701.
5. Bown C.D., Wang J.F., Chen B., Young L.T. Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disord 2002, 2:145-151.
6. Caligiuri M.P., Hellige J.B., Cherry B.J., Kwok W., Lulow L.L., Lohr J.B. Lateralized cognitive dysfunction and psychotic symptoms in schizophrenia. Schizophr Res 2005, 80:151-161.
7. Corson T.W., Woo K.K., et al. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs. Eur Neuropsychopharmacol 2004, 14:143-150.
8. De Lima A.D., Gieseler A., Voigt T. Relationship between GABAergic interneurons migration and early neocortical network activity. Dev Neurobiol 2009, 69:105-123.
9. Gratacos M., et al. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:808-816.
10. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 2009, 15:1016-1022.
11. Hamshere M.L., Bennett P., Williams N., Segurado R., Cardno A., Norton N., et al. "Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 2005, 62:1081-1088.
12. Higashino A., Kageyama T. Development-dependent expression of calreticulin in the brain and other tissues of the Japanese monkey, Macaca fuscata. J Med Primatol 2008, 37:303-310.
13. Jaskolski F., Normand E., Mulle C., Coussen F. Differential trafficking of GluR7 kianate receptor subunit splice variants. J Biol Chem 2005, 280:22968-22976.
14. Keightley P.D., Gaffney D.J. Functional constraints and frequency of deleterious mutations in non-coding DNA of rodents. Proc Natl Acad Sci USA 2003, 100:13402-13406.
15. Kim A.J., Shi Y., Austin R.C., Werstuck G.H. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci 2005, 118:89-99.
16. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochem J 1999, 344:281-292.
17. Mohrluder J., et al. Identification of calreticulin as a ligand of GABARAP by phage display screening of a peptide library. FEBS J 2007, 2:5543-5555.
18. Nakamura M., Sato K., Fukaya M., Araishi K., Aiba A., Kano M., et al. Signaling complex formation of phospholipase Cβ4 with metabotropic glutamate receptor type 1α and 1, 4, 5-trisphosphate receptor at the perisynapse and endoplasmic reticulum in the mouse brain. Eur J Neurol 2004, 20:2929-2944.
19. Nunes A., Ohadi M., Rahimi A., Aghajani A., Najmabadi H., Curraisa A., et al. A mutation in the calreticulin gene promoter in a family case of schizoaffective disorder leads to its aberrant transcriptional activation. Brain Res 2008, 1239:36-41.
20. Ohadi M., Keikhaee M.R., Javanbakht A., Sargolzaee M.R., Robabeh M., Najmabadi H. Gender dimorphism in the DAT1-67T-allele homozygosity and predisposition to bipolar disorder. Brain Res 2007, 1144:142-145.
21. Olkku A., Mahonen A. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells. Bone 2009, 44:555-565.
22. Olad Nabi M., Mirabzadeh A., Feizzadeh G., Khorshid H.R., Karimlou M., Yeganeh M.Z., et al. Novel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:347-349.
23. Sabb F.W., van Erp T.G., Hardt M.E., Dapretto M., Caplan R., Cannon T.D., et al. Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis. Schizophr Res 2010, 116:173-183.
24. Shao L., Sun X., Xu L., Young L.T., Wang J.F. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sci 2006, 78:1317-1323.
25. Subramanian S., Kumar S. Evolutionary anatomies of position and types of disease associated and neutral amino acid mutations in the human genome. BMC Genomics 2006, 7:306-312.
26. Tabuchi A. Synaptic plasticity-regulated gene expression: a key event in the longlasting changes of neuronal function. Biol Pharm Bull 2008, 31:327-335.
27. Van Den Bogaert A., Del-Favero J., Van Broeckhoven C. Major affective disorders and schizophrenia: a common molecular signature?. Hum Mutat 2006, 27:833-853.
28. Villa A., Liste I., Courtois E.T., Seiz E.G., Ramos M., Meyer M., et al. Generation and properties of a new human ventral mesencephalic neural stem cell line. Exp Cell Res 2009, 315:1860-1867.